Molecular characterization of an improved vector for evaluation of the tumor suppressor versus oncogene abilities of the androgen receptor

Ivan V. Litvinov, Lizamma Antony, John T. Isaacs

Research output: Contribution to journalArticlepeer-review

Abstract

BACKGROUND. There is a growing body of evidence demonstrating that the function of the ligand-occupied androgen receptor (AR) within the nuclei of normal prostatic epithelial cells acts as a tumor suppressor gene. This is in contrast to the well-documented ability of the AR within prostate cancer cells to function as an oncogene. Thus, many groups are attempting to understand the biochemistry and signaling cascade differences involved in the switching of AR from a tumor suppressor to an oncogene. METHODS. To do this, of plasmid vectors for transgenic expression of AR are very useful. AR negative PC-3 human prostate cancer cells were transfected with a plasmid containing the full length coding sequence of AR without its 5′- or 3′-untranslated regions (UTRs) (i.e., pSG5-AR). RESULTS. Transgenic expression of the AR protein results in profound growth inhibition which is not relieved by the addition of ligand. A new expression vector for the AR, pAR-IRES-EGFP, has been constructed that contains full-length 5′-UTR which includes the identified translation regulatory regions, the full length coding sequence and the partial 3′-UTR, which includes the identified post-transcriptional regulatory regions. When PC-3 cells were transfected with the pAR-IRES-EGFP vector, it was found that transgenic AR protein expression was not growth inhibitory until ligand was added. CONCLUSIONS. These pSG5-AR versus pSAR-IRES-EGFP clones are being studied to determine the molecular pathways explaining their different response to AR and ligand.

Original languageEnglish (US)
Pages (from-to)299-304
Number of pages6
JournalProstate
Volume61
Issue number4
DOIs
StatePublished - Dec 1 2004

Keywords

  • Androgen receptor (AR)
  • Tumor suppressor
  • pSG5-AR

ASJC Scopus subject areas

  • Oncology
  • Urology

Fingerprint

Dive into the research topics of 'Molecular characterization of an improved vector for evaluation of the tumor suppressor versus oncogene abilities of the androgen receptor'. Together they form a unique fingerprint.

Cite this